ipf

October 20, 2022

New target for lung fibrosis

Blocking thromboxane-prostanoid receptor signaling protected animals from lung fibrosis in preclinical models, suggesting a new treatment for IPF — a chronic, progressive lung disorder that often kills within 3-5 years of diagnosis.

By Leigh MacMillan
X-ray of lungs
October 31, 2011

Lung disorder drug regimen found harmful

Longtime treatment for IPF ineffective and even dangerous.

By Kathy Whitney